Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Szechtman

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 1, 1988
Effect of the dopamine receptor agonist apomorphine on sensory inputH Szechtman
Pharmacology, Biochemistry, and Behavior|June 1, 1986
Effects of pretreatment with naloxone on behaviours induced by a small dose of apomorphineH Szechtman
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1984
Timing of yawns induced by a small dose of apomorphine and its alteration by naloxoneH Szechtman
European Journal of Pharmacology|February 11, 1986
Behavior performed at onset of drug action and apomorphine stereotypyH Szechtman
Neuroscience Letters|February 14, 1986
Lateralized and compulsive exteroceptive orientation in rats treated with apomorphineM Pisa, H Szechtman
Behavioural Pharmacology|January 1, 1993
Environmental modulation of both locomotor response and locomotor sensitization to the dopamine agonist quinpiroleH. Einat, H. Szechtman
Pharmacology, Biochemistry, and Behavior|August 1, 1990
Dosing regimen differentiates sensitization of locomotion and mouthing to D2 agonist quinpiroleD Eilam, H Szechtman
Behavioral Neuroscience|April 1, 1988
Differences in the behavioral profile of circling under amphetamine and apomorphine in rats with unilateral lesions of the substantia nigraM Ziegler, H Szechtman
Behavioural Brain Research|March 31, 1993
Longlasting consequences of chronic treatment with the dopamine agonist quinpirole for the undrugged behavior of ratsH Einat, H Szechtman
European Journal of Pharmacology|November 16, 1979
Pretreatment with delta 1-tetrahydrocannabinol and psychoactive drugs: effects on uptake of biogenic amines and on behaviorM Hershkowitz, H Szechtman
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 1, 1988
Effect of the dopamine receptor agonist apomorphine on sensory inputH Szechtman
Pharmacology, Biochemistry, and Behavior|June 1, 1986
Effects of pretreatment with naloxone on behaviours induced by a small dose of apomorphineH Szechtman
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1984
Timing of yawns induced by a small dose of apomorphine and its alteration by naloxoneH Szechtman
European Journal of Pharmacology|February 11, 1986
Behavior performed at onset of drug action and apomorphine stereotypyH Szechtman
Neuroscience Letters|February 14, 1986
Lateralized and compulsive exteroceptive orientation in rats treated with apomorphineM Pisa, H Szechtman
Behavioural Pharmacology|January 1, 1993
Environmental modulation of both locomotor response and locomotor sensitization to the dopamine agonist quinpiroleH. Einat, H. Szechtman
Pharmacology, Biochemistry, and Behavior|August 1, 1990
Dosing regimen differentiates sensitization of locomotion and mouthing to D2 agonist quinpiroleD Eilam, H Szechtman
Behavioral Neuroscience|April 1, 1988
Differences in the behavioral profile of circling under amphetamine and apomorphine in rats with unilateral lesions of the substantia nigraM Ziegler, H Szechtman
Behavioural Brain Research|March 31, 1993
Longlasting consequences of chronic treatment with the dopamine agonist quinpirole for the undrugged behavior of ratsH Einat, H Szechtman
European Journal of Pharmacology|November 16, 1979
Pretreatment with delta 1-tetrahydrocannabinol and psychoactive drugs: effects on uptake of biogenic amines and on behaviorM Hershkowitz, H Szechtman
Pageof 9